The effect of Indian ink on the identification of involved lymph nodes in breast cancer - Trial IRCT20180720040533N3
Access comprehensive clinical trial information for IRCT20180720040533N3 through Pure Global AI's free database. This phase not specified trial is sponsored by Tehran University of Medical Sciences and is currently Completed. The study focuses on Malignant neoplasm of breast.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Iranian Registry Of Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
IRCT20180720040533N3
Completed
Trial Details
Iranian Registry Of Clinical Trial • IRCT20180720040533N3
The effect of Indian ink on the identification of involved lymph nodes in breast cancer
Preliminary study to evaluate the effectiveness of direct injection of Indian ink and blue methylene in the involved and suspected lymph nodes before and after neoadjuvant chemotherapy in patients with breast cancer and the practical use of this method in detecting theses lymph nodes during surgery.
Study Focus
Interventional
Sponsor & Location
Tehran University of Medical Sciences
Iran
Timeline & Enrollment
N/A
Apr 21, 2022
N/A
ICD-10 Classifications
Malignant neoplasm of breast
Malignant neoplasm of breast
Malignant neoplasm: Breast, unspecified
Malignant neoplasm: Central portion of breast
Personal history of malignant neoplasm of breast
Data Source
Iranian Registry Of Clinical Trial
IRCT20180720040533N3
Non-Device Trial